Primer: Xiamen Yan Palace Bioengineering (1951686D CH) - Aug 2026
Xiamen Yan Palace Bioengineering is a leading player in China's edible bird's nest (EBN) industry, with a strong brand recognition and an...
92 Views
Pre-IPO Xiamen Yan Palace Bioengineering (PHIP Updates) - Some Points Worth the Attention
As Yan palace's revenue growth further declines, effectiveness of marketing activities has already decrease. Huge selling expenses erode profit...
532 Views
Pre-IPO Xiamen Yan Palace Bioengineering - Concerns About Profitability and Growth Sustainability
Since the efficacy/actual value of EBN is questionable, marketing/promotion alone cannot drive future performance growth.Yan Palace's profit model...
699 Views
Xiamen Yan Palace Bioengineering Pre-IPO Tearsheet
Xiamen Yan Palace Bioengineering (1951686D CH) is looking to raise around US$200m in its upcoming Hong Kong IPO. The deal will be run by CICC and...
501 Views
No more insights